Editorial Comment to Interpreting International Real‐World Survival Outcomes After Avelumab First‐Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data
International Journal of Urology · 2026-11 · 33 (11)
DOI: 10.1111/iju.70729 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, online erschienen am 18.11.2026. Verfasst von Soichiro Yoshida und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Science Tokyo, Tokyo, Japan. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Institute of Science Tokyo, Tokyo, Japan.
ORCID-Profile: Soichiro Yoshida, Yasuhisa Fujii
Zitieren
APA
Yoshida, S., & Fujii, Y. (2026). Editorial Comment to Interpreting International Real‐World Survival Outcomes After Avelumab First‐Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data. International Journal of Urology, 33(11). https://doi.org/10.1111/iju.70729
Vancouver
Yoshida S, Fujii Y. Editorial Comment to Interpreting International Real‐World Survival Outcomes After Avelumab First‐Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data. International Journal of Urology. 2026;33(11). doi:10.1111/iju.70729
BibTeX
@article{Yoshida2026,
author = {Yoshida, Soichiro and Fujii, Yasuhisa},
title = {Editorial Comment to Interpreting International Real‐World Survival Outcomes After Avelumab First‐Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data},
journal = {International Journal of Urology},
year = {2026},
volume = {33},
number = {11},
doi = {10.1111/iju.70729}
}
EUVIMED